Cite

    Brian Godman et al.. “Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries.” Expert review of pharmacoeconomics & outcomes research, vol. 20, 2020, pp. 1–26. http://access.bl.uk/ark:/81055/vdc_100105749876.0x000023